Development of nano-micro composite Xiaochaihu decoction granules for enhanced antipyretic and anti-inflammatory efficacy
Analytical Biochemistry · 2026-10 · 717 · 116177
DOI: 10.1016/j.ab.2026.116177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Analytical Biochemistry, 2026-10. Verfasst von Jiantong Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang-Province, 150040, China. Hauptthemen laut MEDLINE: Drugs, Chinese Herbal, Antipyretics, Anti-Inflammatory Agents, Fever. Die Arbeit nennt 46 Literaturangaben. Gefördert von: Heilongjiang Province Natural Science Foundation.
Abstract (Originalsprache)
Traditional liquid decoctions in traditional Chinese medicine (TCM) offer peak efficacy but suffer from physical instability, whereas commercial granules offer stability but often compromise the active nanoscale phase. To bridge this translational gap, a novel "efficacy phase" (EP) state integrating nanophase and suspension features was developed. Here, Xiao-Chai-Hu Decoction efficacy phase (XCHD-EP) was prepared via centrifugation and dialysis. Its solid granule formulation was optimized using Box-Behnken response surface analysis, and quality evaluated via high-performance liquid chromatography (HPLC). A lipopolysaccharide (LPS)-induced rat fever model was utilized to directly compare the in vivo efficacy of XCHD-EP against the raw decoction and commercial granules. Optimal XCHD-EP granules exhibited excellent physical stability. HPLC quantified key components, including baicalin (19.69 mg/g) and saikosaponin A (0.57 mg/g). Pharmacologically, XCHD-EP effectively reversed pyrexia and broadly downregulated key inflammatory mediators (PGE2, NO, cAMP, IL-1β, and IL-6). Crucially, modernized XCHD-EP granules achieved maximal antipyretic and anti-inflammatory efficacies comparable to the freshly prepared raw decoction (p > 0.05), demonstrating robust advantages over existing commercial granules. Grounded strictly in measured physicochemical and functional data, this study successfully translates the pharmacological potency of an unstable decoction into a stable solid form, providing a reliable strategy for TCM modernization.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang-Province, 150040, China.
- College of Pharmacy, Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang-Province, 150040, China. Electronic address: gqxwyb@163.com.
Förderung
- Heilongjiang Province Natural Science Foundation
Zitieren
APA
Shen, J., Xu, Y., Cao, L., Lei, H., Dong, S., Zhang, L., Du, D., & Guan, Q. (2026). Development of nano-micro composite Xiaochaihu decoction granules for enhanced antipyretic and anti-inflammatory efficacy. Analytical Biochemistry, 717, 116177. https://doi.org/10.1016/j.ab.2026.116177
Vancouver
Shen J, Xu Y, Cao L, Lei H, Dong S, Zhang L, et al. Development of nano-micro composite Xiaochaihu decoction granules for enhanced antipyretic and anti-inflammatory efficacy. Analytical Biochemistry. 2026;717:116177. doi:10.1016/j.ab.2026.116177
BibTeX
@article{Shen2026,
author = {Shen, Jiantong and Xu, Yang and Cao, Ling and Lei, Hong and Dong, Shi and Zhang, Long and Du, Dongdong and Guan, Qingxia},
title = {Development of nano-micro composite Xiaochaihu decoction granules for enhanced antipyretic and anti-inflammatory efficacy},
journal = {Analytical Biochemistry},
year = {2026},
volume = {717},
pages = {116177},
doi = {10.1016/j.ab.2026.116177}
}
EUVIMED